We Understand Hemophilia

We know the impact hemophilia can have on the lives of those affected by the disease. Two dedicated families with sons who have hemophilia wanted to make a difference in future treatments for all people with hemophilia. Inspired by their sons' journeys, they founded a different kind of company, Inspiration Biopharmaceuticals. We are the only pharmaceutical company solely focused on the treatment of hemophilia.

Making life with hemophilia easier to manage is at the forefront of everything we do at Inspiration. Because our sole focus is hemophilia, we are able to approach treatment by listening to your needs, your challenges, and your suggestions in order to design solutions that provide the best possible patient experience. Two of our product candidates are in advanced clinical development:

• Recombinant factor IX, IB1001, which is intended for the treatment and prevention of bleeding in people with hemophilia B
• Recombinant porcine factor VIII, OBI-1, which is intended for the treatment of bleeding in people with hemophilia A with inhibitors and acquired hemophilia A

We take the name of our company seriously—we understand the needs of the hemophilia community and are inspired to find solutions that drive positive changes in treatment worldwide.